Annual Symposium on Nonhuman Primates

非人类灵长类动物年度研讨会

• 批准号: 10554035
• 负责人: R. PAUL JOHNSON
• 金额: $ 7.5万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-15 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10554035
• 关键词: AIDS Vaccines; AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Address; Adult; Antibodies; Applications Grants; Budgets; COVID-19 pandemic; COVID-19 pathogenesis; California; Child; Clinic; Clinical; Collaborations; Communicable Diseases; Development; Disease; Emerging Technologies; Fees; Fostering; Funding; Future; Generations; Genomics; Grant; HIV; HIV Infections; HIV Vaccine Trials Network; HIV vaccine; Health; Human; Hybrids; Immunologic Deficiency Syndromes; Immunology; Individual; International; Intervention; Journals; Knowledge; Life; Light; Link; Logistics; Medical; Mentors; Mission; Modeling; NIH Vaccine Research Center; Oral; Oregon; Participant; Pathogenesis; Pennsylvania; Persons; Prevention; Preventive vaccine; Primates; Publishing; Research; Research Personnel; Role; Rotation; SIV; Scientific Advances and Accomplishments; Scientist; Technology; Testing; Translations; United States National Institutes of Health; Vaccines; Virus Diseases; Writing; antiretroviral therapy; base; co-infection; coronavirus disease; cost; disability; experience; falls; global health; meetings; neutralizing antibody; nonhuman primate; novel therapeutics; originality; posters; prevent; programs; response; symposium; therapy design; transmission process; AIDS Vaccines; AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Address; Adult; Antibodies; Applications Grants; Budgets; COVID-19 pandemic; COVID-19 pathogenesis; California; Child; Clinic; Clinical; Collaborations; Communicable Diseases; Development; Disease; Emerging Technologies; Fees; Fostering; Funding; Future; Generations; Genomics; Grant; HIV; HIV Infections; HIV Vaccine Trials Network; HIV vaccine; Health; Human; Hybrids; Immunologic Deficiency Syndromes; Immunology; Individual; International; Intervention; Journals; Knowledge; Life; Light; Link; Logistics; Medical; Mentors; Mission; Modeling; NIH Vaccine Research Center; Oral; Oregon; Participant; Pathogenesis; Pennsylvania; Persons; Prevention; Preventive vaccine; Primates; Publishing; Research; Research Personnel; Role; Rotation; SIV; Scientific Advances and Accomplishments; Scientist; Technology; Testing; Translations; United States National Institutes of Health; Vaccines; Virus Diseases; Writing; antiretroviral therapy; base; co-infection; coronavirus disease; cost; disability; experience; falls; global health; meetings; neutralizing antibody; nonhuman primate; novel therapeutics; originality; posters; prevent; programs; response; symposium; therapy design; transmission process

PROJECT SUMMARY With this R13 application, we request funding to support, in part, the costs for planning, publicizing, and hosting the 39th, 40th, and 41st Annual Symposia on Nonhuman Primate Models for AIDS. For four decades, this symposium has served as the premier scientific forum for the exchange of information, including new research findings and scientific perspectives, among HIV/AIDS investigators whose research includes studies in nonhuman primates (NHPs). Disseminating the latest research findings in NHP models of AIDS while also facilitating discussion and exchange of information between basic scientists and clinicians remains a priority, as do focusing on emerging technologies to accelerate translation of NHP studies into the clinic and engaging a broader and more diverse group of researchers in HIV/AIDS research in NHP models. This meeting, the only one of its kind in the world, convenes an international group of scientists whose research focuses on the study of natural and experimental immunodeficiency virus infections in NHPs, as well as on the development of novel therapeutics, prophylactic vaccines for HIV, and curative approaches. Emerging topics in related infectious diseases (such as COVID-19 pathogenesis, vaccines and treatment) may also be included. The seven National Primate Research Centers (NPRCs) host this meeting in rotation, and upcoming symposia hosts will be the Yerkes (2022), California (2023), and Tulane (2024) NPRCs. We plan a hybrid format with most participants attending in person and others joining online to access oral and poster sessions. The conference will begin on day 1 with registration, a keynote address by a leading HIV/AIDS researcher, and an evening reception. The following two and a half days will include scientific presentations from invited speakers and accepted oral abstracts. Each symposium scientific committee will select session topics and speakers to highlight new and cutting-edge technologies in their respective fields. Each session will open with a 30-minute talk by an invited chair. Individuals whose abstracts are accepted for oral presentations will give the remaining session talks. A poster session will occur on the evening of day 2, and there will be a banquet on the evening of day 3. As is traditional for this symposium, the Journal of Medical Primatology will publish all poster and oral abstracts in a special issue. In partnership with the HIV Vaccine Trials Network (HVTN), the NHP AIDS Symposium will also host a pre-symposium meeting for early stage investigators (ESI). This meeting will be open to the attendees of a linked ESI Conference the HVTN sponsors. ESI attendees and mentors will focus on grant writing, budgeting, and networking, and will participate in a Q&A with NIH Program Officers. We believe bringing together researchers from a variety of diverse backgrounds will generate future collaborations and scientific advances. Knowledge shared and gained at upcoming Annual Nonhuman Primate Models for AIDS Symposia will further the continued, effective use of NHP models to maintain long term control of HIV replication in the absence of antiretroviral therapy and to design interventions to prevent or eradicate HIV infection.

项目摘要 通过此R13申请，我们要求资助以部分支持计划，宣传和托管的费用 第39，第40和第41届年度艾滋病的非人类灵长类动物模型。四十年来，这个 研讨会曾是信息交换的主要科学论坛，包括新研究 在艾滋病毒/艾滋病研究人员中，发现和科学观点的研究包括 非人类灵长类动物（NHP）。在NHP的艾滋病模型中传播最新的研究结果 促进基础科学家和临床医生之间信息的讨论和交流仍然是当务之急 正如专注于新兴技术以加速NHP研究转化为诊所并参与的新兴技术 NHP模型中艾滋病毒/艾滋病研究方面的更广泛，更多样化的研究人员。这次会议，唯一 世界上之一，召集了一群国际科学家，其研究重点是研究 NHP中的天然和实验性免疫缺陷病毒感染以及新颖的发展 治疗剂，HIV的预防性疫苗和治疗方法。相关传染性的新兴主题 还可以包括疾病（例如19号发病机理，疫苗和治疗）。七个国民 灵长类动物研究中心（NPRCS）主持此会议，即将举行的研讨会主持人将是 Yerkes（2022），加利福尼亚（2023）和Tulane（2024）NPRCS。我们与大多数参与者计划混合格式 亲自参加和其他人在线参加口头和海报会议。会议将开始 第一天的注册，由领先的艾滋病毒/艾滋病研究员的主题演讲和晚间接待。这 遵循两天半的时间将包括受邀演讲者的科学演讲和接受口头的演讲 摘要。每个研讨会科学委员会都会选择会议主题和发言人，以突出新的和 各自领域的尖端技术。每个会议将通过邀请的30分钟演讲开始 椅子。接受口头演示的摘要的个人将进行剩余的会议谈判。一个 海报会议将在第2天的晚上举行，第3天晚上将举行宴会。 该研讨会的传统，《医学启示杂志》将在 专刊。与HIV疫苗试验网络（HVTN）合作，NHP AIDS研讨会也将 举办了早期研究人员（ESI）的群众前会议。这次会议将向与会者开放 链接的ESI会议HVTN赞助商。 ESI的与会者和导师将专注于赠款写作， 预算和网络，并将与NIH计划官员一起参加问答。我们相信带来 来自各种不同背景的研究人员将共同产生未来的合作和科学 进步。在即将举行的AIDS研讨会的年度非人类灵长类动物模型中共享并获得的知识 将进一步有效利用NHP模型来维持对HIV复制的长期控制 没有抗逆转录病毒疗法并设计干预措施以预防或消除HIV感染。